Roser Solans

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 52 publications

Genetic biomarkers of clinical manifestations in giant cell arteritis define distinct patient subgroups.

Genetic biomarkers of clinical manifestations in giant cell arteritis define distinct patient subgroups.

Journal: Annals of the rheumatic diseases

Published: March 25, 2026

Sex disparities in the phenotype at diagnosis of Sjögren's disease: artificial intelligence-driven characterisation in 17,416 patients.

Sex disparities in the phenotype at diagnosis of Sjögren's disease: artificial intelligence-driven characterisation in 17,416 patients.

Journal: Clinical and experimental rheumatology

Published: September 18, 2025

Immunological signatures in patients with Sjögren's disease: association with systemic disease activity at diagnosis.

Immunological signatures in patients with Sjögren's disease: association with systemic disease activity at diagnosis.

Journal: Clinical and experimental rheumatology

Published: September 18, 2025

Mepolizumab versus benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA): A European real-life retrospective comparative study.

Mepolizumab versus benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA): A European real-life retrospective comparative study.

Journal: Journal of autoimmunity

Published: December 09, 2024

Antiphospholipid syndrome autoantibodies induction after treatment with anti-TNF alpha therapy in patients with IBD.

Antiphospholipid syndrome autoantibodies induction after treatment with anti-TNF alpha therapy in patients with IBD.

Journal: Gastroenterologia y hepatologia

Published: July 12, 2024

Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study.

Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study.

Journal: The Lancet. Rheumatology

Published: November 07, 2023

Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort study.

Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort study.

Journal: The Lancet. Rheumatology

Published: May 11, 2023

Mortality risk factors in primary Sjögren syndrome: a real-world, retrospective, cohort study.

Mortality risk factors in primary Sjögren syndrome: a real-world, retrospective, cohort study.

Journal: EClinicalMedicine

Published: February 03, 2023

The complex HLA-E-nonapeptide in Behçet disease.

The complex HLA-E-nonapeptide in Behçet disease.

Journal: Frontiers in immunology

Published: October 25, 2022

Sequential rituximab and mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA): a European multicentre observational study.

Sequential rituximab and mepolizumab in eosinophilic granulomatosis with polyangiitis (EGPA): a European multicentre observational study.

Journal: Annals of the rheumatic diseases

Published: May 09, 2022

Systemic phenotype related to primary Sjögren's syndrome in 279 patients carrying isolated anti-La/SSB antibodies.

Systemic phenotype related to primary Sjögren's syndrome in 279 patients carrying isolated anti-La/SSB antibodies.

Journal: Clinical and experimental rheumatology

Published: August 17, 2020

SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients.

SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients.

Journal: Rheumatology (Oxford, England)

Published: August 11, 2020

Showing 1-12 of 52

Last Updated: 09/26/2026